Literature DB >> 12451037

Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer.

Sachiko Tanaka1, Akihiko Nakaizumi, Tatsuya Ioka, Osamu Oshikawa, Hiroyuki Uehara, Miho Nakao, Kiyomi Yamamoto, Osamu Ishikawa, Hiroaki Ohigashi, Tsugio Kitamra.   

Abstract

BACKGROUND: The prognosis of pancreatic ductal adenocarcinoma remains very poor, but is better in patients with a small tumor without local infiltration. The identification of the sign of high risk for pancreatic cancer will lead to early detection and improvement of the prognosis of this disease. The purpose of this study was to evaluate the main pancreatic duct dilatation as a sign of high risk for pancreatic cancer.
METHODS: The diameter of the main pancreatic duct was measured by ultrasonography. The proportion of cases with main pancreatic duct dilatation was retrospectively examined in a pre-cancer group (39 subjects in whom pancreatic cancer developed more than 1 year later and surgically resected) and in a control group (10 244 subjects). Then the proportions in both groups were compared using the odds ratio.
RESULTS: The proportion of cases with a slight dilatation (>/=2 mm in diameter) of the main pancreatic duct was 65% in the pre-cancer group, more than 4 years before the resection of the pancreatic cancer. In contrast, it was 5.35% in the age-matched control subjects. The odds ratio of 32.5 (95% confidence interval: 10.9-107.3) shows a significant association between the main pancreatic duct dilatation and the pre-cancer condition. Moreover, the proportion and the mean diameter of the dilated duct in the pre-cancer group increased with time.
CONCLUSION: Slight dilatation of the main pancreatic duct appears to be a sign of high risk for pancreatic cancer. The systematic examination of high-risk subjects is recommended for the early detection of pancreatic cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12451037     DOI: 10.1093/jjco/hyf093

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  19 in total

1.  Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer.

Authors:  Yukiko Sugiyama; Yasunari Fujinaga; Masumi Kadoya; Kazuhiko Ueda; Masahiro Kurozumi; Hideaki Hamano; Shigeyuki Kawa
Journal:  Jpn J Radiol       Date:  2012-01-12       Impact factor: 2.374

Review 2.  Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas.

Authors:  Masayuki Kitano
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

Review 3.  Ultrasonographic diagnostic criteria for pancreatic cancer.

Authors: 
Journal:  J Med Ultrason (2001)       Date:  2013-10       Impact factor: 1.314

Review 4.  CT and MR features that can help to differentiate between focal chronic pancreatitis and pancreatic cancer.

Authors:  Sitthipong Srisajjakul; Patcharin Prapaisilp; Sirikan Bangchokdee
Journal:  Radiol Med       Date:  2020-01-13       Impact factor: 3.469

Review 5.  Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.

Authors:  Hiroyuki Matsubayashi
Journal:  J Gastroenterol       Date:  2011-08-17       Impact factor: 7.527

6.  Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.

Authors:  Touseef Ahmad Qureshi; Srinivas Gaddam; Ashley Max Wachsman; Lixia Wang; Linda Azab; Vahid Asadpour; Wansu Chen; Yibin Xie; Bechien Wu; Stephen Jacob Pandol; Debiao Li
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

7.  Clinical significance of main pancreatic duct dilation on computed tomography: single and double duct dilation.

Authors:  Mark-D Edge; Maarouf Hoteit; Amil-P Patel; Xiaoping Wang; Deborah A Baumgarten; Qiang Cai
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

8.  Indicative findings of pancreatic cancer in prediagnostic CT.

Authors:  Sung Soo Ahn; Myeong-Jin Kim; Jin-Young Choi; Hye-Suk Hong; Yong Eun Chung; Joon Seok Lim
Journal:  Eur Radiol       Date:  2009-05-05       Impact factor: 5.315

9.  Double-duct sign in the era of endoscopic ultrasound: the prevalence of occult pancreaticobiliary malignancy.

Authors:  Jonah Cohen; Mandeep S Sawhney; Douglas K Pleskow; Ram Chuttani; Nirav J Patel; Jennifer Sheridan; Tyler M Berzin
Journal:  Dig Dis Sci       Date:  2014-04-05       Impact factor: 3.199

10.  A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography.

Authors:  Junko Fukuda; Sachiko Tanaka; Nobuko Ishida; Tatsuya Ioka; Kenji Ikezawa; Rena Takakura; Miho Nakao; Kazuyoshi Ohkawa; Kazuhiro Katayama; Shigenori Nagata
Journal:  J Med Ultrason (2001)       Date:  2018-02-22       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.